| **x**  | ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF        THE SECURITIES EXCHANGE ACT OF 1934:         For the fiscal year ending December 31, 2007                   |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                          |
| **o**  | TRANSITION REPORT UNDER SECTION 13 OR 15(d)        OF THE SECURITIES EXCHANGE ACT OF 1934:         For the transition period from ___________ to ___________. |
| Delaware                                                                         |   | 98-0513637                                    |
|----------------------------------------------------------------------------------|--------|-----------------------------------------------|
| (State or other jurisdiction          of incorporation or          organization) |   | (I.R.S. Employer Identification          No.) |
|                                                                             |   |                                          |

----

|       |                                                                                                                  | Page         No |
|------------|-----------------------------------------------------------------------------------------------------------------------|-----------------|
|       |                                                                                                                  |            |
| PART I     |                                                                                                                  | 1               |
|       |                                                                                                                  |                 |
| ITEM 1.    | Description of Business                                                                                               | 1               |
|       |                                                                                                                  |                 |
| ITEM 2.    | Description of Property                                                                                               | 6               |
|       |                                                                                                                  |                 |
| ITEM 3.    | Legal Proceedings                                                                                                     | 6               |
|       |                                                                                                                  |                 |
| ITEM 4.    | Submission of Matters to a Vote of Security Holders                                                                   | 6               |
|       |                                                                                                                  |                 |
| PART II    |                                                                                                                       | 6               |
|       |                                                                                                                  |                 |
| ITEM 5.    | Market for Common Equity and Related Stockholder Matters                                                              | 6               |
|       |                                                                                                                  |                 |
| ITEM 6.    | Management's Discussion and Analysis or Plan of Operation                                                             | 7               |
|       |                                                                                                                  |                 |
| ITEM 7.    | Financial Statement                                                                                                   | 10              |
|       |                                                                                                                  |                 |
| ITEM 8.    | Changes in and Disagreements with Accountants on Accounting      and Financial Disclosure                             | 10              |
|       |                                                                                                                  |                 |
| ITEM 8A.   | Controls and Procedures                                                                                               | 10              |
|       |                                                                                                                  |                 |
| PART III   |                                                                                                                  | 11              |
|       |                                                                                                                  |                 |
| ITEM 9.    | Directors, Executive Officers, Promoters,      and Control Persons; Compliance with Section 16(a) of the Exchange Act | 11              |
|       |                                                                                                                  |                 |
| ITEM 10.   | Executive Compensation                                                                                                | 11              |
|       |                                                                                                                  |                 |
| ITEM 11.   | Security Ownership of Certain Beneficial Owners and Management                                                        | 20              |
|       |                                                                                                                  |                 |
| ITEM 12.   | Certain Relationships and Related Transactions                                                                        | 13              |
|       |                                                                                                                  |                 |
| ITEM 13.   | Exhibits                                                                                                              | 13              |
|       |                                                                                                                  |                 |
| ITEM 14.   | Principal Accounting Fees and Services                                                                                | 13              |
|       |                                                                                                                  |                 |
| Signatures | 13                                                                                                                    |

----

----

----

----

| • | that a broker or dealer approve a person's      account for transactions in penny stocks; and                                                                                |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                                         |
| • | the broker or dealer receive from the investor      a written agreement to the transaction, setting forth the identity and quantity      of the penny stock to be purchased. |

| • | obtain financial information and investment      experience objectives of the person; and                                                                                                                                                                            |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                                                                                                                                 |
| • | make a reasonable determination that the transactions      in penny stocks are suitable for that person and the person has sufficient      knowledge and experience in financial matters to be capable of evaluating      the risks of transactions in penny stocks. |

----

| • | sets forth the basis on which the broker or      dealer made the suitability determination; and                 |
|--------|-----------------------------------------------------------------------------------------------------------------|
|   |                                                                                                            |
| • | that the broker or dealer received a signed,      written agreement from the investor prior to the transaction. |

----

----

----

----

| • | Disclosure of the objectives for using derivative      instruments be disclosed in terms of underlying risk and accounting designation; |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------|
| • | Disclosure of the fair values of derivative      instruments and their gains and losses in a tabular format;                            |
| • | Disclosure of information about credit-risk-related      contingent features; and                                                       |
| • | Cross-reference from the derivative footnote      to other footnotes in which derivative-related information is disclosed.              |

----

----

|              |   |                                                      |   | Annual Compensation |   | Long Term Compensation |
|-------------------|--------|-----------------------------------------------------------|--------|---------------------|--------|------------------------|
| Name              |   | Title                                                     |   | Year                |   |                   | Salary |   | Bonus |   | Other         Annual        Compensation |   | Restricted         Stock         Awarded |   | Options/         SARs         (#) |   | LTIP         payouts         ($) |   | All Other        Compensation |
| Krystal Rocha     |   | Director,       President,      CEO, CFO,       Secretary |   | 2007                |   | $                      | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
|              |   |                                                      |   |                |   |                   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Oren Rozenberg    |   | Former      President      CEO                            |   | 2007                |   | $                      | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
|              |   |                                                      |   |                |   |                   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Judah Steinberger |   | Former      Secretary                                     |   | 2007                |   | $                      | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |

----

| **Name and Address of Beneficial Owner (1)**                                                            | **Amount and         Nature of        Beneficial         Ownership** |   | **Percentage of        Common Stock(3)** |   |
|---------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------|--------|------------------------------------------|--------|
|                                                                                                    |                                                                 |   |                                     |   |
| Rocky Global Enterprises      Ltd.      Frontstreet 5, Suite 5      Philipsburg, St. Maarten            | 1,000,000                                                            |   | 33%                                      |   |
| Krystal Rocha, President & Director      Nominee      24955 Pacific Coast Highway      Malibu, CA 90265 | 0%                                                                   |   | 0%                                       |   |
| Beaux Beaux Partnership      115 Reynosa Road      Carencro, La.                                        | 934,250                                                              |   | 31%                                      |   |
| All Directors and executive officers as a group                                                         | 0%                                                                   |   | 0%                                       |   |
| Total Beneficial Owners(2)                                                                              | 1,934,250                                                            |   | 64%                                      |   |

|   | (1) | Unless otherwise indicated in the footnotes      to the table, each shareholder shown on the table has sole voting and investment      power with respect to the shares beneficially owned by him or it. |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | (2) | Based on 3,025,000 shares of Common Stock outstanding.                                                                                                                                                   |

----

| 31.1 (2) | Certification of the Chief Executive Officer      and Chief Financial/Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley      Act of 2002.                                                |
|----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 32.1 (2) | Certification of Chief Executive Officer and      Chief Financial/Accounting Officer pursuant to 18 U.S.C. Section 1350, as      Adopted, pursuant to section 906 of the Sarbanes-Oxley act of 2002 (2) |

| Signature              |   | Title                                             |   | Date           |
|------------------------|--------|---------------------------------------------------|--------|----------------|
|                   |   | Director,                                         |   |           |
| /s/      Krystal Rocha |   | Chief Executive Officer, President, and Secretary |   | April 14, 2008 |
| Krystal Rocha          |   |                                              |   |           |

----

| Report of Registered Independent Auditors                                                                                                                                                                                                                    | F-2    |   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|
|                                                                                                                                                                                                                                                         |   |   |
| Financial Statements-                                                                                                                                                                                                                                        |   |   |
|                                                                                                                                                                                                                                                         |   |   |
|       Balance      Sheet as of December 31, 2007                                                                                                                                                                               | F-3    |   |
|                                                                                                                                                                                                                                                         |   |   |
|       Statements      of Operations for the Year Ended December 31, 2007,                        the Period Ended December 31, 2006, and Cumulative from Inception | F-4    |   |
|                                                                                                                                                                                                                                                         |   |   |
|       Statements      of Stockholders' Equity (Deficit) for the Periods from Inception                        (October 23, 2006) through December 31, 2007         | F-5    |   |
|                                                                                                                                                                                                                                                         |   |   |
|       Statements      of Cash Flows for the Year Ended December 31, 2007,                        the Period Ended December 31, 2006, and Cumulative from Inception | F-6    |   |
|                                                                                                                                                                                                                                                         |   |   |
|       Notes      to Financial Statements December 31, 2007, and 2006                                                                                                                                                           | F-7    |   |

----

----

|                                                                                                                                                                                                                            |   | **2007** |   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|----------|--------|
| **Other Assets:**                                                                                                                                                                                                          |   |     |   |
|       Patent      pending                                                                                                                                                                    | $      | 15,560   |   |
| **Total Assets**                                                                                                                                                                                                           | $      | 15,560   |   |
|                                                                                                                                                                                                                       |   |     |   |
| **LIABILITIES AND STOCKHOLDERS' EQUITY**                                                                                                                                                                                   |
| **Current Liabilities:**                                                                                                                                                                                                   |   |          |   |
|       Accounts      Payable - Trade                                                                                                                                                          | $      | 5,035    |   |
|       Accrued      liabilities                                                                                                                                                               |   | 5,000    |   |
|             Total      current liabilities                                                                                                                     |   | 10,035   |   |
|             Total      liabilities                                                                                                                             |   | 10,035   |   |
| **Commitments and Contingencies**                                                                                                                                                                                          |   |          |   |
| **Stockholders' Equity:**                                                                                                                                                                                                  |   |          |   |
|       Common      stock, par value $0.0001 per share, 50,000,000                shares authorized;      3,025,000 shares issued and outstanding |   | 302      |   |
|       Additional      paid-in capital                                                                                                                                                        |   | 68,648   |   |
|       (Deficit)      accumulated during the development stage                                                                                                                                |   | (63,425  | )      |
|             Total      stockholders' equity                                                                                                                    |   | 5,525    |   |
| **Total Liabilities and Stockholders' Equity**                                                                                                                                                                             | $      | 15,560   |   |
|                                                                                                                                                                                                                       |   |     |   |

----

|                                                                                                                                                            | **Year Ended         December 31,        2007** |      | **Period Ended        December 31,         2006** |   | **Cumulative        From         Inception** |   |
|------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------|-----------|---------------------------------------------------|--------|----------------------------------------------|--------|
|                                                                                                                                                       |                                            |      |                                              |   |                                         |   |   |   |   |
| **Revenues**                                                                                                                                               | $                                               | -         |                                              | $      | -                                            |   | $ | - |   |
| **Expenses:**                                                                                                                                              |                                            |      |                                              |   |                                         |   |   |   |   |
|       General      and administrative-                                                                                       |                                            |      |                                              |   |                                         |   |   |   |   |
|             Legal      fees - Incorporation                                                    |                                            | -         |                                              |   | 1,500                                        |   |   | 1,500 |   |
|             Professional      fees                                                             |                                            | 47,666    |                                              |   | 3,900                                        |   |   | 51,566 |   |
|             Other                                                                              |                                            | 9,771     |                                              |   | 588                                          |   |   | 10,359 |   |
|                   Total      general and administrative expenses |                                            | 57,437    |                                              |   | 5,988                                        |   |   | 63,425 |   |
| **(Loss) from Operations**                                                                                                                                 |                                            | (57,437   | )                                                 |   | (5,988                                       | )      |   | (63,425 | ) |
| **Other Income (Expense)**                                                                                                                                 |                                            | -         |                                              |   | -                                            |   |   | - |   |
| **Provision for Income Taxes**                                                                                                                             |                                            | -         |                                              |   | -                                            |   |   | - |   |
| **Net (Loss)**                                                                                                                                             | $                                               | (57,437   | )                                                 | $      | (5,988                                       | )      | $ | (63,425 | ) |
|                                                                                                                                                       |                                            |      |                                              |   |                                         |   |   |   |   |
| **(Loss) Per Common Share:**                                                                                                                               |                                            |      |                                              | $      |                                              |   |   |   |   |
|       (Loss)      per common share - Basic and Diluted                                                                       | $                                               | (0.02     | )                                                 | $      | (0.02                                        | )      |   |   |   |
|                                                                                                                                                       |                                            |      |                                              |   |                                         |   |   |   |   |
| **Weighted Average Number of Common Shares                  Outstanding - Basic and Diluted**                                |                                            | 2,518,151 |                                              |   | 285,714                                      |   |   |   |   |
|                                                                                                                                                       |                                            |      |                                              |   |                                         |   |   |   |   |

----

| ****                                 |   | **Common stock** |   | **Additional        Paid-in** |       | **(Deficit)        Accumulated        During the        Development** |   |        |   |   |
|--------------------------------------|--------|------------------|--------|-------------------------------|------------|-----------------------------------------------------------------------|--------|-------------|--------|--------|
| **Description**                      |   | **Shares**       |   |                          | **Amount** |                                                                  |   | **Capital** |   |   | **Stage** |   |   | **Totals** |   |
| **Balance - October 23,      2006**  |   | -                |   | $                             | -          |                                                                  | $      | -           |   | $      | - |   | $ | - |   |
| Common stock issued for cash         |   | 2,000,000        |   |                          | 200        |                                                                  |   | -           |   |   | - |   |   | 200 |   |
| Net (loss) for the period            |   | -                |   |                          | -          |                                                                  |   | -           |   |   | (5,988 | ) |   | (5,988 | ) |
| **Balance - December 31, 2006**      |   | 2,000,000        |   |                          | 200        |                                                                  |   | -           |   |   | (5,988 | ) |   | (5,788 | ) |
| Common stock issued for services     |   | 25,000           |   |                          | 2          |                                                                  |   | 1,998       |   |   | - |   |   | 2,000 |   |
| Common stock issued for cash         |   | 1,000,000        |   |                          | 100        |                                                                  |   | 99,900      |   |   | - |   |   | 100,000 |   |
| Deferred offering costs              |   | -                |   |                          | -          |                                                                  |   | (33,250     | )      |   | - |   |   | (33,250 | ) |
| Net (loss) for the period            |   | -                |   |                          | -          |                                                                  |   | -           |   |   | (57,437 | ) |   | (57,437 | ) |
| **Balance - December 31,      2007** |   | 3,025,000        |   | $                             | 302        |                                                                  | $      | 68,648      |   | $      | (63,425 | ) | $ | 5,525 |   |
|                                 |   |             |   |                          |       |                                                                  |   |        |   |   |   |   |   |   |   |

----

|                                                                                                                                                                               | **Year Ended         December 31,        2007** |     | **Period Ended        December 31,         2006** |   | **Cumulative        From         Inception** |   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------|----------|---------------------------------------------------|--------|----------------------------------------------|--------|
|                                                                                                                                                                          |                                            |     |                                              |   |                                         |   |   |   |   |
| **Operating Activities:**                                                                                                                                                     |                                            |     |                                              |   |                                         |   |   |   |   |
|         Net      (loss)                                                                                                               | $                                               | (57,437  | )                                                 | $      | (5,988                                       | )      | $ | (63,425 | ) |
|         Adjustments      to reconcile net (loss) to net cash (used in) operating activities:                                          |                                            |          |                                              |   |                                              |   |   |  |   |
|                 Transfer      agent fees paid by issued shares                                |                                            | 2,000    |                                              |   | -                                            |   |   | 2,000 |   |
|                 Changes      in net liabilities-                                              |                                            |          |                                              |   |                                              |   |   |  |   |
|                         Accounts      payable - Trade |                                            | 5,035    |                                              |   | -                                            |   |   | 5,035 |   |
|                         Accrued      liabilities      |                                            | (6,750   | )                                                 |   | 11,750                                       |   |   | 5,000 |   |
| **Net Cash Provided by (Used in) Operating      Activities**                                                                                                                  |                                            | (57,152) |                                              |   | 5,762                                        |   |   | (51,390 | ) |
| **Investing Activities:**                                                                                                                                                     |                                            |          |                                              |   |                                              |   |   |  |   |
|         Acquisition      and costs of patent pending                                                                                  |                                            | -        |                                              |   | (15,560                                      | )      |   | (15,560 | ) |
| **Net Cash (Used in) Investing      Activities**                                                                                                                              |                                            | -        |                                              |   | (15,560                                      | )      |   | (15,560 | ) |
| **Financing Activities:**                                                                                                                                                     |                                            |          |                                              |   |                                              |   |   |  |   |
|         Issuance      of common stock for cash                                                                                        |                                            | 100,000  |                                              |   | 200                                          |   |   | 100,200 |   |
|         Deferred      offering costs                                                                                                  |                                            | (23,250  | )                                                 |   | (10,000                                      | )      |   | (33,250 | ) |
|         Loans      from related parties - Former Directors and stockholders                                                           |                                            | 20,000   |                                              |   | 19,800                                       |   |   | 39,800 |   |
|         Payment      of loans from related parties - Former Directors and stockholders                                                |                                            | (39,800  | )                                                 |   | -                                            |   |   | (39,800 | ) |
|         Loan      from third-party entity related to consultant                                                                       |                                            | -        |                                              |   | 15,000                                       |   |   | 15,000 |   |
|         Repayment      of loan from third-party entity related to consultant                                                          |                                            | -        |                                              |   | (15,000                                      | )      |   | (15,000 | ) |
| **Net Cash Provided by Financing      Activities**                                                                                                                            |                                            | 56,950   |                                              |   | 10,000                                       |   |   | 66,950 |   |
| **Net Increase in Cash and Cash Equivalents**                                                                                                                                 |                                            | (202     | )                                                 |   | 202                                          |   |   | - |   |
| **Cash and Cash Equivalents      - Beginning of Period**                                                                                                                      |                                            | 202      |                                              |   | -                                            |   |   | - |   |
| **Cash and Cash Equivalents - End of Period**                                                                                                                                 | $                                               | -        |                                              | $      | 202                                          |   | $ | - |   |
|                                                                                                                                                                          |                                            |     |                                              |   |                                         |   |   |   |   |
| **Supplemental Disclosure      of Cash Flow Information:**                                                                                                                    |                                            |     |                                              |   |                                         |   |   |   |   |
|         Cash      paid during the period for:                                                                                         |                                            |     |                                              |   |                                         |   |   |   |   |
|                 Interest                                                                      | $                                               | -        |                                              | $      | -                                            |   | $ | - |   |
|                                                                                                                                                                          |                                            |     |                                              |   |                                         |   |   |   |   |
|                 Income      taxes                                                             | $                                               | -        |                                              | $      | -                                            |   | $ | - |   |
|                                                                                                                                                                          |                                            |     |                                              |   |                                         |   |   |   |   |

----

----

----

----

----

|   |                                                                                                                                    | **Year Ended        December 31,        2007** |    | **Period Ended        December 31,        2006** |   |   |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------|---------|--------------------------------------------------|--------|--------|
|   | Current Tax Provision:                                                                                                                  |                                           |    |                                             |   |   |   |   |
|   |          Federal      and state-                                                           |                                           |    |                                             |   |   |   |   |
|   |              Taxable      income                                       | $                                              | -       |                                             | $      | -      |   |   |
|   |                  Total      current tax provision  | $                                              | -       |                                             | $      | -      |   |   |
|   |                                                                                                                                    |                                           |    |                                             |   |   |   |   |
|   | Deferred Tax Provision:                                                                                                                 |                                           |    |                                             |   |   |   |   |
|   |          Federal      and state-                                                           |                                           |    |                                             |   |   |   |   |
|   |              Loss      carryforwards                                   | $                                              | 13,210  |                                             | $      | 1,377  |   |   |
|   |              Change      in valuation allowance                        |                                           | (13,210 | )                                                |   | (1,377 | ) |   |
|   |                  Total      deferred tax provision | $                                              | -       |                                             | $      | -      |   |   |
|   |                                                                                                                                    |                                           |    |                                             |   |   |   |   |

|   |                                                                                                                                     | **2007** |    | **2006** |   |   |
|--------|------------------------------------------------------------------------------------------------------------------------------------------|----------|---------|----------|--------|--------|
|   |          Loss      carryforwards                                                            | $        | 14,587  |     | $      | 1,377  |   |   |
|   |          Less      - Valuation allowance                                                    |     | (14,587 | )        |   | (1,377 | ) |   |
|   |                  Total      net deferred tax assets | $        | -       |     | $      | -      |   |   |
|   |                                                                                                                                     |     |    |     |   |   |   |   |

----

----

| • | Disclosure of the objectives for using derivative      instruments be disclosed in terms of underlying risk and accounting designation; |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------|
| • | Disclosure of the fair values of derivative      instruments and their gains and losses in a tabular format;                            |
| • | Disclosure of information about credit-risk-related      contingent features; and                                                       |
| • | Cross-reference from the derivative footnote      to other footnotes in which derivative-related information is disclosed.              |

----